{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CNY", "shortName": "JIANGSU YAHONG MEDITECH CO LTD", "messageBoardId": "finmb_716464312", "exchangeTimezoneShortName": "CST", "market": "cn_market", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "exchange": "SHH", "longName": "Jiangsu Yahong Meditech Co., Ltd.", "regularMarketChangePercent": -2.6000023, "regularMarketPrice": 14.61, "exchangeTimezoneName": "Asia/Shanghai", "marketState": "POSTPOST", "regularMarketChange": -0.39000034, "regularMarketTime": 1683874801, "regularMarketDayHigh": 15.1, "regularMarketDayRange": "14.56 - 15.1", "regularMarketDayLow": 14.56, "regularMarketVolume": 2728648, "regularMarketPreviousClose": 15.0, "bid": 14.6, "ask": 14.68, "fullExchangeName": "Shanghai", "financialCurrency": "CNY", "regularMarketOpen": 15.07, "averageDailyVolume3Month": 5006406, "averageDailyVolume10Day": 4150385, "fiftyTwoWeekLowChange": 4.5999994, "fiftyTwoWeekLowChangePercent": 0.4595404, "fiftyTwoWeekRange": "10.01 - 18.36", "fiftyTwoWeekHighChange": -3.750001, "fiftyTwoWeekHighChangePercent": -0.20424841, "fiftyTwoWeekLow": 10.01, "fiftyTwoWeekHigh": 18.36, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.46, "sharesOutstanding": 570000000, "bookValue": 4.741, "fiftyDayAverage": 15.5806, "fiftyDayAverageChange": -0.9706001, "fiftyDayAverageChangePercent": -0.06229543, "twoHundredDayAverage": 13.06495, "twoHundredDayAverageChange": 1.5450497, "twoHundredDayAverageChangePercent": 0.11825913, "marketCap": 8327699968, "priceToBook": 3.081628, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1641519000000, "priceHint": 2, "symbol": "688176.SS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building B, Qiantan World Trade Center", "address2": "19th Floor, Phase III Lane 221, Dongyu Road Pudong New Area", "city": "Shanghai", "zip": "200126", "country": "China", "phone": "86 21 6858 3863", "fax": "86 21 6858 5281", "website": "https://www.asieris.cn", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Jiangsu Yahong Meditech Co., Ltd. engages in the research and development, production, and commercialization of drugs for genitourinary system tumors and other diseases in China and internationally. Its pipeline includes APL-1202, an anti-tumor drug, which is in Phase III clinical trial for the treatment of non-muscle invasive bladder cancer; APL-1501, an oral MetAP inhibitor that is in Phase I clinical trial for the treatment of urinary system tumors and drug-resistant urinary tract infections; APL-1706, an agent drug, which is in Phase III clinical trial for the treatment of non-muscle invasive bladder cancer; and APL-1702, a photodynamic therapy product that is in Phase III clinical trial for the treatment of cervical high-grade squamous intraepithelial lesions of the cervix caused by infection of HPV subtypes. In addition, it develops targeted protein degraders which are in preclinical stage comprising ASN-1764 for the treatment of triple negative breast cancer; ASN-1780 for the treatment of metastatic castration-resistant prostate cancer; and APL-1901 for the treatment of ER positive breast cancer. Further, the company develops APL-1401 to treat moderately to severely active ulcerative colitis; and ASN-1733 to treat acinetobacter baumannii infection. Jiangsu Yahong Meditech Co., Ltd. was founded in 2010 and is based in Shanghai, China.", "fullTimeEmployees": 231, "companyOfficers": [{"maxAge": 1, "name": "Dr. Kevin  Pan", "age": 54, "title": "Founder, Chairman & CEO", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Chengfeng  Zhuang", "age": 59, "title": "Deputy GM & Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "David  Wilson Ph.D.", "title": "Sr. VP of BD", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Alice  Chen", "title": "VP of Discovery Biology & Head of Translational Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Linda  Wu Ph.D.", "title": "Chief Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}